Recurrent Cutaneous Myoepithelioma Treated Using Mohs Micrographic Surgery

Miller, Tara D.; McCalmont, Timothy; Tope, Whitney D.

doi:10.1097/00042728-200901000-00022

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Myoepithelioma1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(2 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Complete resection seems to be the optimal therapeutic approach for benign lesions [11,247,264,281,298]. Some of them may recur, although the metastatic potential is low and surgical treatment may be performed more than once [80,257,268,285,287,290].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Apocrine and Eccrine Differentiation

Płachta

Kleibert

Czarnecka

et al. 2021

IJMS

View full text Add to dashboard Cite

Adnexal tumors of the skin are a rare group of benign and malignant neoplasms that exhibit morphological differentiation toward one or more of the adnexal epithelium types present in normal skin. Tumors deriving from apocrine or eccrine glands are highly heterogeneous and represent various histological entities. Macroscopic and dermatoscopic features of these tumors are unspecific; therefore, a specialized pathological examination is required to correctly diagnose patients. Limited treatment guidelines of adnexal tumor cases are available; thus, therapy is still challenging. Patients should be referred to high-volume skin cancer centers to receive an appropriate multidisciplinary treatment, affecting their outcome. The purpose of this review is to summarize currently available data on pathogenesis, diagnosis, and treatment approach for apocrine and eccrine tumors.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Myoepithelioma is considered a benign lesion; therefore, surgical excision with clear margins is performed (Table 2) [290,298]. The lesion may recur, although the metastatic potential is low [287,290].…”

Section: Myoepitheliomamentioning

confidence: 99%